remainder was used for blood serum. Plasma was prepared without use of anticoagulants as follows:
Screw-capped 15 X 180 mm. tubes were placed in 50 ml. centrifuge buckets (International Centrifuge Co., cat. no. 320). The buckets were then filled with water, keeping the tubes centered and immersed with an adapter ring and a top weight. These were placed in the freezing compartment of the refrigerator the day prior to use. Up to 12 ml. of blood was delivered into each ice-jacketed tube immediately after cardiac or venous puncture; the tubes were then promptly spun in a refrigerated centrifuge (1800 G, 20 rain., 2°C.). The clear fluid plasma layer was withdrawn and placed in another tube. After incubation for 1 hour at 38°C. the clot which had formed was removed by twirling on a loop or by centrifuging at 1800 G for 15 minutes.
Satisfactory preparation of plasma by this technique was indicated by a clean separation of cells after centrifuging in the cold. On some occasions clinging of material, presumably platelets and cells, was noted on the walls of the tube about the plasma layer. Plasma serum from such specimens manifested properties intermediate between those of blood serum and dean plasma serum; presumably some of the early phenomena of the dotting process had taken place in these instances, perhaps in association with undetectable trauma at the time of puncture, delay in chilling, or inadequately treated glassware. In any event, those specimens showing signs of unsatisfactory separation of plasma were discarded.
Platelet-rich plasma was prepared in the same way, but at a slower speed of centrifugation (60 6"). Platelet counts were done on the plasma layer by diluting it in saline and counting in a Petroff-Hausser chamber under phase contrast illumination. These preparations conrained on various occasions 150,000 to 250,000 platelets per c.mm., and were essentially free of leucocytes and red cells (less than 250 per c.mm.).
The portion of blood intended for preparation of blood serum was placed at 38°C. for 1 hour and, after rimming of the clot, was centrifuged at room temperature, 1800 G for 15 minutes to allow separation of the serum.
Bacteria were cultured on penassay agar slants. Overnight growth was collected in sterile physiological saline containing a final concentration of 0.05 per cent bovine albumin (Pentex, Inc., Kankakee, Illinois). The bacteria were washed once in the centrifuge, and were then suspended in saline-albumin in 15 X 180 ram. tubes to a standard optical density (O. D. = 0.5 at 650 X).
Bactericidal tests were performed by making twofold serial dilutions of serum samples in the saline-albumin solution described above. In some experiments Gey's balanced salt solution was also employed as a diluting medium with identical results. The serum dilutions (0.9 ml. each) were then inoculated with 0.1 ml. of a 1:1000 dilution of the bacterial suspension. After incubation for 1 hour at 38°C., 0.1 ml. aliquots of suitable dilutions of the samples were spread on well dried penassay agar plates. Colonies were counted after overnight incubation at 38°C. and numbers of surviving microorganisms were calculated. The end point selected was the highest serum dilution producing greater than a 50 per cent reduction in numbers of viable bacteria as compared to the control sample containing no serum.
Rabbit polymorphonuclear leucocytes, obtained from peritoneal exudates as described previously (4), were washed in Gey's solution and added to certain plasma samples as described in the text. Red cells employed for a similar operation were obtained from heparinized blood; they were washed repeatedly with saline in the centrifuge.
RESULTS

Comparative Bactericidal Activity of Rabbit Blood Serum and Rabbit Plasma
Serum.--Bactericidal activity of serum from whole blood, of heat-inactivated blood serum, and of serum obtained from plasma allowed to clot in the absence of formed elements was measured on several microorganisms. Results of a representative study are shown in Table I . The various serum preparations were derived from a single sample of rabbit blood. It is seen that quite small amounts of rabbit blood serum manifested a lethal effect on three Grampositive microbes, Bacillus subtilis, Bacillus megaterium, and Staphylococcus aureus 2 (Giorgio strain). This bactericidal action of blood serum was relatively heat-stable. In sharp contrast, even high concentrations of serum prepared from plasma of the same blood did not kill these microbes.
Results of studies on three Gram-negative bacilli, Escherichia coll K-12, 
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* Bactericidal activity in this and the following tables is recorded as the reciprocal of the highest 2-fold dilution producing more than 50 per cent kill of the inoculated microorganisms.
Proteus morganii, and Shigella sonnei were quite different. Blood serum and plasma serum exerted the same lethal action on these microbes, and bactericidal activity was completely lost following heat inactivation.
Studies on the Origin of the Bactericidal Agent for Bacillus subtilis in Blood
Serum.--Since previous investigators had noted certain similarities and also differences between properties of the heat-stable serum bactericidin and lysozyme (5), the concentration of this enzyme was measured in rabbit blood serum and rabbit plasma serum, using with slight modification the method of Shugar (6) . No significant differences in lysozyme content were found.
Next, experiments were done to determine whether an antimicrobial agent might be liberated when cellular elements or platelets were present during the clotting process. The results are presented in Table II . Again it is seen that blood serum manifested striking bactericidal activity, whereas plasma serum was essentially without effect. Platelet-rich plasma prepared by low Among the several strains of coagulase-positive staphylococci maintained in this department, the Giorgio strain was the only one killed by normal rabbit serum.
speed centrifugation of chilled blood produced serum with a lethal property for B. subtilis similar to that of blood serum. In contrast, plasma enriched with granulocytes or red cells did not. Furthermore, addition of leucocytes or red cells to the platelet-rich plasma failed further to enhance antimicrobial action of the serum exuded after clotting. Of special interest was the fact that only low levels of bactericidal activity appeared on incubation of platelet-rich * The formed elements were included or added to give the following final concentrations: platelets 200,000 per c.mm., polymorphonuclear leucocytes 10,000 per c.mm., and erythrocytes 1,000,000 per c.mm. plasma when dotting was prevented by addition of citrate or heparin. Extracts obtained by incubating platelets or polymorphonuclear leucocytes in saline were capable of killing the test microbe, but quantitatively this effect was much less than that of blood serum or of platelet-rich plasma serum. Finally, full bactericidal activity on B. subtilis failed to develop when rabbit blood was defibrinated by shaking with glass beads and incubated at 38°C. for 1 hour before separation of serum in the centrifuge.
Further experiments, recorded in Table III , served to confirm the relationship between the presence of platelets in rabbit plasma and the appearance of bactericidal activity in the fluid after clotting. Centrifugation of chilled rabbit blood in various gravitational fields permitted collection of plasma samples containing platelets in concentrations ranging from none to 200,000 per c.mm. In all instances the lethal effect on B. subtilis of the sera derived from these plasma preparations was approximately proportional to the concentration of platelets in them.
Comparative Bactericidal Acti~y of Human Blood Serum and Plasma Serum.--
Results of similar studies done on human blood are shown in Table IV . Human blood serum exhibited only a low level of bactericidal activity on B. subtilis as compared to that of rabbit blood serum (see Table I ). Furthermore, serum from human plasma killed this microbe as effectively as did blood serum.
When tested for ability to inactivate Escherickia coli K-12, both human blood serum and plasma serum were considerably more active than the corresponding rabbit preparations and, as expected, this activity was lost on heating to 56°C. 
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DISCUSSION
Every since the early studies in the 19th century on antibacterial effects of blood serum, a controversy has existed concerning the origin and nature of the substances responsible for this property. To date this controversy has been only partially resolved (reviewed in reference 7). According to current beliefs two distinct types of bactericidal activity can be detected in serum: (a) lethal effects on certain Gram-positive microorganisms (e.g. aerobic spore formers and some micrococci), an action which is due to substances of unknown nature, often called beta lysins, and which is further characterized by its relative heat stability; and (b) killing of Gram-negative bacteria (e.g. coliforms), a heatlabile property usually attributed to the action of the complement system and antibody. Results of the present investigation further support the concept that at least two distinct bactericidal systems are present in rabbit blood serum. In addition to those differences just mentioned, the heat-stable system is absent from plasma serum, whereas heat-labile bactericidal action is present in plasma serum to the same degree as in blood serum.
Metchnikoff and coworkers originally speculated that the antibacterial effects of serum were in the main, if not entirely, due to release of "microcytases" from leucocytes during the clotting process (1). This concept now seems untenable; evidence presented here clearly demonstrates that lethal action on Gram-negative bacilli is present in serum collected following coagulation of cell-free plasma. Furthermore, the present experiments indicate that release into serum during the clotting process of a bactericidin for Grampositive microbes depends upon the presence of platelets, not leucocytes.
The precise role of platelets in formation of a heat-stable serum bactericidin is not entirely clear from the studies done thus far. Several facts suggest that this agent is not simply a readily extractible platelet component: full lethal activity on B. subtilis does not appear on incubation of platelet-rich plasma when clotting is prevented with anticoagulants, nor is it produced in saline suspensions of platelets, or even on incubation of defibrinated blood. The results suggest, rather, that this antibacterial factor arises either from platelets or from plasma constituents and that both the presence of platelets and the process of coagulation are prerequisites for its complete formation and/or release. Considering the complexity of the clotting process and of the chemical composition of platelets, precise identification of the bactericidin may well prove to be a difficult task.
The present results confirm previous findings of differences in lethal effects on B. subtilis of sera of various animals (5). Rabbit serum manifests this action to a high degree, whereas human serum does so only to a slight extent.
Some previous investigators have suggested that complement does not exist in a complete and active form in circulating plasma, and that release of CP4 or other factors from leucocytes during clotting may be responsible for its activation (reviewed in reference 7). In the present work, complement, at least as measured by its bactericidal effects, was equally demonstrable in blood serum and plasma serum. Thus, if complement does in fact exist in a precursor state in circulating plasma, its activation must be due to the clotting process itself, rather than to release of material from leucocytes or platelets.
Many writers have commented on the fact that rabbit serum manifests a high order of bactericidal activity on the anthrax bacillus, yet the rabbit is quite susceptible to anthrax infection. The present findings provide a possible explanation for this paradox. Since the serum anthracidal agent is probably the same or similar to that which kills the related B. subtilis and B. megaterium, it probably does not exist in active form in circulating plasma of the rabbit, and may play no significant role in host resistance to anthrax invasion. On the other hand, in certain infections or potentially infected lesions associated with local blood clotting (e.g. coagulase-positive staphylococcal disease, surgical or traumatic wounds), beta lysins may well be liberated and exert antimicrobial effects.
Use of serum from clotted blood has become a standard procedure for investigating a wide range of biological processes. The resuks presented in this report emphasize that substances from leucocytes and platelets, as well as from the coagulation process itself, may be present in blood serum but not in circulating plasma. Collection of plasma serum by the technique outlined here is relatively simple and rapid. It eliminates two of the possible sources of contaminants, platelets and cells, of blood serum, and might be useful in many studies which employ or investigate the fluid portion of blood. su~rM~Ry Rabbit and human plasma can be prepared without resort to anticoagulants by employing low temperatures and non-wetting surfaces. Serum formed after clotting of rabbit plasma devoid of cells and platelets manifests essentially no bactericidal activity on Bacillus subtilis, Bacillus megaterium, and a strain of Staphylococcus aureus. In contrast, rabbit blood serum exhibits this activity to a high degree.
Rabbit plasma rich in platelets gives rise to a serum with capacity to kill these Gram-positive microbes equal to that of serum prepared from whole blood. This heat-stable antibacterial agent is efficiently formed or released when platelets are present during the coagulation of plasma, but not on incubation of platelets in heparinized or citrated plasma or in saline. Leucocytes and red ceils appear to play no significant role in its production.
Rabbit blood serum and plasma serum have similar heat-labile lethal effects on enteric bacilli.
Human serum, whether from blood or plasma, manifests much less bactericidal activity on Bacillus subtilis than does rabbit blood serum.
These findings serve to emphasize the fact that substances formed or released during coagulation of whole blood may impart to the serum activities not present in circulating plasma. 
